Exclusive patent and know-how license and sublicense to develop, use, import, offer, advertise, promote, distribute, sell and sublicense therapeutic products which contain Lutenizing Hormone Releasing Hormone (LHRH) antagonist compounds, for any therapeutic uses, including treatment of prostate cancer, breast cancer, endometriosis, uterine fibroids, benign prostatic hypertrophy, infertility, and precocious puberty.